A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "METHOD OF TREATMENT OF CANCER PAIN WITH TANEZUMAB"
Published: February 07, 2023 by U.S. Fed News
Executive Perspective: Pfizer CEO states 2023 pipeline may have the largest number of new product and indication launches they’ve ever had; Pfizer expects to introduce 19 new products or indications to the market in next 18 months
Published: February 06, 2023 by Outsourcing-Pharma.com
FDA to convene advisors to review experimental RSV vaccine candidate from Pfizer on February 28; group to meet in March to reviews RSV vaccine candidate from GSK
Published: February 03, 2023 by BioPharma Dive
Australia Patent: Pfizer Files Application for 'Human cytomegalovirus gB polypeptide'
Published: February 03, 2023 by Australian Government
Australia: Pfizer Receives Patent for 'Streptococcus pneumoniae capsular polysaccharides and conjugates thereof'
Published: February 03, 2023 by Australian Government

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count